Crewe Advisors’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.4K | Hold |
150
| – | – | ﹤0.01% | 431 |
|
|
2025
Q1 | $12.2K | Hold |
150
| – | – | ﹤0.01% | 410 |
|
|
2024
Q4 | $13.5K | Hold |
150
| – | – | ﹤0.01% | 401 |
|
|
2024
Q3 | $14.8K | Hold |
150
| – | – | ﹤0.01% | 436 |
|
|
2024
Q2 | $13.9K | Hold |
150
| – | – | ﹤0.01% | 620 |
|
|
2024
Q1 | $14.2K | Buy |
+150
| New | +$14.2K | ﹤0.01% | 557 |
|
|
2023
Q3 | – | Sell |
-80
| Closed | -$6.66K | – | 932 |
|
|
2023
Q2 | $6.66K | Hold |
80
| – | – | ﹤0.01% | 441 |
|
|
2023
Q1 | $6.1K | Hold |
80
| – | – | ﹤0.01% | 613 |
|
|
2022
Q4 | $6.64K | Hold |
80
| – | – | ﹤0.01% | 623 |
|
|
2022
Q3 | $6K | Hold |
80
| – | – | ﹤0.01% | 828 |
|
|
2022
Q2 | $6K | Hold |
80
| – | – | ﹤0.01% | 730 |
|
|
2022
Q1 | $7K | Hold |
80
| – | – | ﹤0.01% | 379 |
|
|
2021
Q4 | $9K | Hold |
80
| – | – | ﹤0.01% | 319 |
|
|
2021
Q3 | $10K | Hold |
80
| – | – | ﹤0.01% | 270 |
|
|
2021
Q2 | $11K | Hold |
80
| – | – | ﹤0.01% | 275 |
|
|
2021
Q1 | $11K | Hold |
80
| – | – | ﹤0.01% | 280 |
|
|
2020
Q4 | $11K | Buy |
80
+61
| +321% | +$8.39K | ﹤0.01% | 257 |
|
|
2020
Q3 | $2K | Buy |
+19
| New | +$2K | ﹤0.01% | 544 |
|
|
2019
Q2 | – | Sell |
-34
| Closed | -$3K | – | 312 |
|
|
2019
Q1 | $3K | Hold |
34
| – | – | ﹤0.01% | 213 |
|
|
2018
Q4 | $2K | Hold |
34
| – | – | ﹤0.01% | 221 |
|
|
2018
Q3 | $3K | Sell |
34
-130
| -79% | -$11.5K | ﹤0.01% | 225 |
|
|
2018
Q2 | $16K | Hold |
164
| – | – | 0.01% | 192 |
|
|
2018
Q1 | $14K | Hold |
164
| – | – | 0.01% | 208 |
|
|
2017
Q4 | $14K | Buy |
+164
| New | +$14K | 0.01% | 205 |
|